Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the time of management's...

PolyAI, a leader in enterprise conversational AI, today announced it has been recognized in multiple 2025 Gartner reports, including the Hype Cycle for Customer Service and Support Technologies...

PolyAI, a leader in enterprise conversational AI, today announced it has been recognized in multiple 2025 Gartner reports, including the Hype Cycle for Customer Service and Support Technologies...

AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025. Management will participate in a fireside chat at 9:00 a.m....

Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced...

ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS from Sept. 12 - 15 in Copenhagen, Denmark: EFFICIENT, CONFIDENT DECISION MAKING: introducing...

Safety & efficacy of iza-bren, an EGFRxHER3 bispecific topoisomerase inhibitor- based antibody-drug conjugate (ADC), in patients with EGFR mutated Non-Small Cell Lung Cancer (NSCLC), both as...

Poster presentations included overviews of plans and designs for the global Phase 3 Beeline trial of investigational radiprodil in GRIN-related neurodevelopmental disorder (GRIN-NDD) and Phase...

Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...